Patents by Inventor Susan R. Watson

Susan R. Watson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL MODULATORS
    Publication number: 20220227857
    Abstract: Antibodies that modulate insulin receptor signaling are provided.
    Type: Application
    Filed: January 13, 2022
    Publication date: July 21, 2022
    Inventors: John Corbin, Mark Leslie White, Susan R. Watson, Vinay Bhaskar
  • Modulators
    Patent number: 11261247
    Abstract: Antibodies that modulate insulin receptor signaling are provided.
    Type: Grant
    Filed: March 14, 2018
    Date of Patent: March 1, 2022
    Assignee: XOMA (US) LLC
    Inventors: John Corbin, Mark Leslie White, Susan R. Watson, Vinay Bhaskar
  • C10RF32 ANTIBODIES, AND USES THEREOF FOR TREATMENT OF CANCER
    Publication number: 20200002416
    Abstract: This invention relates to C1ORF32-specific antibodies, antibody fragments, alternative scaffolds, conjugates and compositions comprising same, for treatment of cancer.
    Type: Application
    Filed: May 14, 2019
    Publication date: January 2, 2020
    Inventors: Gady S. COJOCARU, Galit ROTMAN, Zurit LEVINE, Liat DASSA, Ofer LEVI, Raffaella BRIANTE, Shweta SINGH, Susan R. WATSON, Tania PERGAM
  • Novel Modulators
    Publication number: 20180371081
    Abstract: Antibodies that modulate insulin receptor signaling are provided.
    Type: Application
    Filed: March 14, 2018
    Publication date: December 27, 2018
    Inventors: John A. Corbin, Mark Leslie White, Susan R. Watson, Vinay Bhaskar
  • Modulators
    Patent number: 9944698
    Abstract: Antibodies that modulate insulin receptor signaling are provided.
    Type: Grant
    Filed: November 26, 2014
    Date of Patent: April 17, 2018
    Assignee: XOMA (US) LLC
    Inventors: John Corbin, Mark Leslie White, Susan R. Watson, Vinay Bhaskar
  • C10RF32 ANTIBODIES, AND USES THEREOF FOR TREATMENT OF CANCER
    Publication number: 20170233473
    Abstract: This invention relates to C1ORF32-specific antibodies, antibody fragments, alternative scaffolds, conjugates and compositions comprising same, for treatment of cancer.
    Type: Application
    Filed: February 28, 2017
    Publication date: August 17, 2017
    Applicant: Compugen Ltd.
    Inventors: Gady S. COJOCARU, Galit ROTMAN, Zurit LEVINE, Liat DASSA, Ofer LEVI, Raffaella BRIANTE, Shweta SINGH, Susan R. WATSON, Tania PERGAM
  • Modulators
    Patent number: 9725510
    Abstract: Antibodies that modulate insulin receptor signaling are provided.
    Type: Grant
    Filed: November 26, 2014
    Date of Patent: August 8, 2017
    Assignee: XOMA (US) LLC
    Inventors: John Corbin, Mark Leslie White, Susan R. Watson, Vinay Bhaskar
  • C10RF32 antibodies, and uses thereof for treatment of cancer
    Patent number: 9617336
    Abstract: This invention relates to C1ORF32-specific antibodies, antibody fragments, alternative scaffolds, conjugates and compositions comprising same, for treatment of cancer.
    Type: Grant
    Filed: January 31, 2013
    Date of Patent: April 11, 2017
    Assignee: COMPUGEN LTD
    Inventors: Gady S. Cojocaru, Galit Rotman, Zurit Levine, Liat Dassa, Ofer Levi, Raffaella Briante, Shweta Singh, Susan R. Watson, Tania Pergam
  • Novel Modulators
    Publication number: 20160009800
    Abstract: Antibodies that modulate insulin receptor signaling are provided.
    Type: Application
    Filed: November 26, 2014
    Publication date: January 14, 2016
    Inventors: JOHN CORBIN, MARK LESLIE WHITE, SUSAN R. WATSON, VINAY BHASKAR
  • Novel Modulators
    Publication number: 20150322157
    Abstract: Antibodies that modulate insulin receptor signaling are provided.
    Type: Application
    Filed: November 26, 2014
    Publication date: November 12, 2015
    Inventors: John Corbin, Mark Leslie White, Susan R. Watson, Vinay Bhaskar
  • C10RF32 ANTIBODIES, AND USES THEREOF FOR TREATMENT OF CANCER
    Publication number: 20150158947
    Abstract: This invention relates to C1ORF32-specific antibodies, antibody fragments, alternative scaffolds, conjugates and compositions comprising same, for treatment of cancer.
    Type: Application
    Filed: January 31, 2013
    Publication date: June 11, 2015
    Applicant: COMPUGEN LTD.
    Inventors: Gady S. Cojocaru, Galit Rotman, Zurit Levine, Liat Dassa, Ofer Levi, Raffaella Briante, Shweta Singh, Susan R. Watson, Tania Pergam
  • Modulators
    Patent number: 8926976
    Abstract: Antibodies that modulate insulin receptor signaling are provided.
    Type: Grant
    Filed: September 24, 2010
    Date of Patent: January 6, 2015
    Assignee: Xoma Technology Ltd.
    Inventors: John Corbin, Mark Leslie White, Susan R. Watson, Vinay Bhaskar
  • Novel Modulators
    Publication number: 20110076284
    Abstract: Antibodies that modulate insulin receptor signaling are provided.
    Type: Application
    Filed: September 24, 2010
    Publication date: March 31, 2011
    Applicant: XOMA TECHNOLOGY LTD.
    Inventors: John Corbin, Mark L. White, Susan R. Watson, Vinay Bhaskar
  • Methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators
    Publication number: 20040033495
    Abstract: Described herein are methods and compositions that can be used for diagnosis and treatment of angiogenic phenotypes and angiogenesis-associated diseases. Also described herein are methods that can be used to identify modulators of angiogenesis.
    Type: Application
    Filed: August 1, 2002
    Publication date: February 19, 2004
    Applicant: Eos Biotechnology, Inc.
    Inventors: Richard Murray, Richard Glynne, Susan R. Watson, Natasha Aziz
  • Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
    Publication number: 20030232350
    Abstract: Described herein are genes whose expression are up-regulated or down-regulated in specific cancers or other diseases, or are otherwise regulated in disease. Related methods and compositions that can be used for diagnosis, prognosis, and treatment of those medical conditions are disclosed. Also described herein are methods that can be used to identify modulators of these selected conditions.
    Type: Application
    Filed: November 13, 2002
    Publication date: December 18, 2003
    Applicant: Eos Biotechnology, Inc.
    Inventors: Daniel Afar, Natasha Aziz, Wendy M. Ginsburg, Kurt C. Gish, Richard Glynne, Peter A. Hevezi, David H. Mack, Richard Murray, Susan R. Watson, Keith E. Wilson, Albert Zlotnik
  • Novel methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators
    Publication number: 20030152926
    Abstract: Described herein are methods and compositions that can be used for diagnosis and treatment of angiogenic phenotypes and angiogenesis-associated diseases. Also described herein are methods that can be used to identify modulators of angiogenesis.
    Type: Application
    Filed: December 6, 2001
    Publication date: August 14, 2003
    Applicant: Eos Biotechnology, Inc.
    Inventors: Richard Murray, Richard Glynne, Susan R. Watson